I certainly do think. Exactly that. But consider-you note
I certainly do think. Exactly that. But consider-you note that Remdesivir is being given WITH Brilicidin and then Remdesivir is being given AS the "placebo". IF one ASSUMES that Remdesivir has NO (or even very low) effect on the patients, then what WOULD be causing ANY AND ALL effects? It seems one MIGHT THEN ASSUME that the candidate drug (insert your favorite IPIX property HERE) IS causing any (MOST? ALL?) oberved effects?
As I said, assumption is often incorrect. But the fact is there will be a certain level of placebo effect. Unavoidable and often a statistically predictable value. Since, in this current Brilicidin, the SOC comparator being used is Remdesivir, and since Brilicidin is being given with Remdesivir in the treatment arm, if Remdesivir is increasingly viewed as relatively ineffective, the what might a person ASSUME TO BE the cause of any positive results that are seen? It seems that, IF one assumes Remdesivir is having little to no effect, then there is only one other thing it could be.
This possible view that Remdesivir has even less effectiveness than some previoiusly may have thought is not particularly good for the "blinding" of the study. But it doesn't seem like it will invalidate anything related to the study results either. My speculation is whether any perceived view of a possible loss of "blinding" (again, some speculation "someone" might jump to) might spur someone to do something sooner than they might otherwise have done. I know this is verbous and long but I hope what I'm saying is clear. Maybe this will make it more clear. GOOOO BRILICIDIN!!!!
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...
Continue Reading
Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...
Continue Reading
Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...
Continue Reading
Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...
Continue Reading
Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...
Continue Reading
Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...
Continue Reading
A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...
Continue Reading
USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...
Continue Reading
Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...
Continue Reading
Top 5 Most Recently Viewed Articles
Sisram Medical Showcases Impressive Third-Quarter Performance HONG KONG – Sisram Medical Ltd, known for its innovative contributions to medical aesthetics, has reported robust growth for the third quarter of 2025. The company is renowned for its Energy-Based Devices (EBD), injectables, and complementary solutions, solidifying its position in the global consumer wellness...
Continue Reading
Robbins LLP Investigates Xerox Holdings Class Action Claims Robbins LLP is currently reaching out to investors who have experienced significant losses in Xerox Holdings Corporation (NASDAQ: XRX). The law firm has announced that a class action lawsuit has been filed on behalf of individuals and entities who purchased or acquired XRX securities during a specified period....
Continue Reading
Innovative Collaborations in Focusing on Metabolic Diseases Novo Nordisk A/S is taking significant strides in the fight against obesity and related health concerns through two strategic partnerships. Recently, they announced an expanded agreement with Valo Health, aimed at discovering and developing advanced treatments for obesity, type 2 diabetes, and cardiovascular...
Continue Reading
Recent Developments in Myeloma Treatment Johnson & Johnson has made significant strides recently, demonstrating strong clinical efficacy with an innovative immune-based treatment for multiple myeloma. The combination of Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase) has showcased remarkable effectiveness in newly diagnosed patients who are...
Continue Reading
Walee Financial Services Celebrates Hakeem's Distinction Walee Financial Services is excited to announce a significant achievement as its revolutionary fintech product, Hakeem, has recently been awarded the Emerging FinTech Award at the prestigious Singapore FinTech Festival Excellence Awards. This event, supported by the Monetary Authority of Singapore (MAS) along with...
Continue Reading